FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

38135511000001105: Forxiga 5mg tablets (DE Pharmaceuticals) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 18-Mar 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1240021000001110 Forxiga 5mg tablets (DE Pharmaceuticals) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1240041000001117 Forxiga 5mg tablets (DE Pharmaceuticals) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Forxiga 5mg tablets (DE Pharmaceuticals) Has specific active ingredient Dapagliflozin propanediol monohydrate true Inferred relationship Existential restriction modifier
Forxiga 5mg tablets (DE Pharmaceuticals) Is a Dapagliflozin 5mg tablets false Inferred relationship Existential restriction modifier
Forxiga 5mg tablets (DE Pharmaceuticals) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Forxiga 5mg tablets (DE Pharmaceuticals) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Forxiga 5mg tablets (DE Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Forxiga 5mg tablets (DE Pharmaceuticals) Is a Dapagliflozin 5mg tablets true Inferred relationship Existential restriction modifier
Forxiga 5mg tablets (DE Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Forxiga 5mg tablets (DE Pharmaceuticals) Is a Product containing precisely dapagliflozin propanediol 5 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Forxiga 5mg tablets (DE Pharmaceuticals) Is a Forxiga true Inferred relationship Existential restriction modifier
Forxiga 5mg tablets (DE Pharmaceuticals) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Forxiga 5mg tablets (DE Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Dapagliflozin false Inferred relationship Existential restriction modifier
Forxiga 5mg tablets (DE Pharmaceuticals) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Forxiga 5mg tablets (DE Pharmaceuticals) Has specific active ingredient Dapagliflozin propanediol monohydrate false Inferred relationship Existential restriction modifier
Forxiga 5mg tablets (DE Pharmaceuticals) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Forxiga 5mg tablets (DE Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Forxiga 5mg tablets (DE Pharmaceuticals) 30 tablet Has AMP True Forxiga 5mg tablets (DE Pharmaceuticals) Inferred relationship Existential restriction modifier
Forxiga 5mg tablets (DE Pharmaceuticals) 28 tablet Has AMP True Forxiga 5mg tablets (DE Pharmaceuticals) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start